Media

The Biotechnology Innovation Organization (BIO) is pleased to announce that the Honorable Dennis McGinn, Assistant Secretary of the Navy, Energy, Installations...
BIO Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday’s proposed Part B Drug Payment Model and...

Press Releases

Dec 11 2003
WASHINGTON, D.C. (December 11, 2003) - Advance media registration is now open for the Biotechnology Industry Organization (BIO) CEO & Investor Conference...
Nov 25 2003
(Washington, D.C.) November 25, 2003—Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement...
Nov 17 2003
WASHINGTON, D.C. (November 17, 2003)— Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement in response...
Nov 12 2003
WASHINGTON, D.C. (November 12, 2003) — During testimony today before the Senate Subcommittee on Securities and Investment, Walter K. Moore, vice president for...
Nov 10 2003
WASHINGTON, D.C. (November 10, 2003) -- The U.S. Commerce Department will release a new report, A Survey of the Use of Biotechnology in U.S. Industry, at a...
Nov 3 2003
Washington, D.C. (November 3, 2003) – Gillian Woollett, the Biotechnology Industry Organization's vice president for science and regulatory affairs, issued the...
Oct 31 2003
WASHINGTON (October 31, 2003) – Lisa Dry, communications director of the Biotechnology Industry Organization (BIO), issued the following statement in response...
Oct 27 2003
The Department of Commerce's Office of Technology Policy/Technology Administration (OTP/TA) and the Office of Strategic Industries and Economic Security,...
Oct 21 2003
WASHINGTON, D.C. (October 21, 2003) – The Biotechnology Industry Organization (BIO), in coordination with the Greater Philadelphia Venture Group (GPVG), a...